Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:54 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Eventide Asset Management, LLC | 3,179,837 5.150% | 3,179,837 (New Position) | Filing History |
| 2024-02-14 11:48 am Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Eventide Asset Management, LLC | 3,630,013 6.640% | 3,630,013 (New Position) | Filing History |
| 2023-12-11 5:15 pm Purchase | 2023-11-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 11,559,975 16.340% | 3,745,936 (+47.94%) | Filing History |
| 2023-12-11 5:14 pm Purchase | 2023-11-30 | 13G | Aura Biosciences, Inc. AURA | Eventide Asset Management, LLC | 5,802,682 11.820% | 3,551,314 (+157.74%) | Filing History |
| 2023-12-11 5:13 pm Purchase | 2023-11-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 3,002,831 11.930% | 3,002,831 (New Position) | Filing History |
| 2023-11-13 4:10 pm Purchase | 2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE | Eventide Asset Management, LLC | 1,394,336 9.990% | 1,394,336 (New Position) | Filing History |
| 2023-11-13 2:43 pm Purchase | 2023-10-31 | 13G | Xometry, Inc. XMTR | Eventide Asset Management, LLC | 5,730,339 12.650% | 5,730,339 (New Position) | Filing History |
| 2023-10-10 3:40 pm Purchase | 2023-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 7,814,039 11.070% | 7,814,039 (New Position) | Filing History |
| 2023-02-14 3:04 pm Unchanged | 2022-12-31 | 13G | Vital Farms, Inc. VITL | Eventide Asset Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 0 0.000% | -2,708,975 (Position Closed) | Filing History |
| 2023-02-14 2:50 pm Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | Eventide Asset Management, LLC | 0 0.000% | -3,318,647 (Position Closed) | Filing History |
| 2023-02-14 2:37 pm Unchanged | 2022-12-31 | 13G | Zymeworks Inc. ZYME | Eventide Asset Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:06 pm Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | Eventide Asset Management, LLC | 3,405,644 5.400% | 1,066,600 (+45.60%) | Filing History |
| 2023-02-14 1:58 pm Sale | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Eventide Asset Management, LLC | 1,032,938 2.200% | -2,709,569 (-72.40%) | Filing History |
| 2023-02-14 1:54 pm Purchase | 2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Eventide Asset Management, LLC | 394,718 9.100% | 162,341 (+69.86%) | Filing History |
| 2023-02-14 1:48 pm Sale | 2022-12-31 | 13G | Cogent Biosciences, Inc. COGT | Eventide Asset Management, LLC | 2,589,778 3.700% | -925,131 (-26.32%) | Filing History |
| 2023-02-14 1:40 pm Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | Eventide Asset Management, LLC | 3,626,508 7.600% | 776,508 (+27.25%) | Filing History |
| 2023-02-14 1:38 pm Sale | 2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Eventide Asset Management, LLC | 234,537 7.500% | -19,502 (-7.68%) | Filing History |
| 2023-02-14 1:36 pm Sale | 2022-12-31 | 13G | KnowBe4, Inc. KNBE | Eventide Asset Management, LLC | 0 0.000% | -4,177,983 (Position Closed) | Filing History |
| 2023-02-14 1:34 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 2,057,000 5.600% | 2,057,000 (New Position) | Filing History |